Use of tin as a surfactant material for the growth of thin silver films on silicon oxide

In this letter, we report on the use of tin as an effective surfactant material for silver growing on silicon oxide. We observed that submonolayers of Sn pre-deposited on SiO₂ result in earlier film coalescence and formation of smoother Ag layers. We suggest that Sn atoms reduce the Ag-adatom mobility resulting in experimentally observed increased island density and decreased film roughness. Angle-resolved X-ray photoelectron spectroscopy reveals that Sn remains under the Ag layer giving circumstantial evidence that at later stages of Ag film growth Sn does not influence the interlayer transport.     

Negative sulfur-based electrodes and their application in battery cells: Dual-ion batteries as an example

Journal of Solid State Electrochemistry - In this work, a cell concept comprising of an anion intercalating graphite-based positive electrode (cathode) and an elemental sulfur-based negative...     

Systematic re-evaluation of the bis(2-hydroxyethyl)disulfide (HEDS) assay reveals an alternative mechanism and activity of glutaredoxins

The reduction of bis(2-hydroxyethyl)disulfide (HEDS) by reduced glutathione (GSH) is the most commonly used assay to analyze the presence and properties of enzymatically active glutaredoxins (Grx), a family of central redox proteins in eukaryotes and glutathione-utilizing prokaryotes. Enzymatically active Grx usually prefer glutathionylated disulfide substrates. These are converted via a ping-pong mechanism. Sequential kinetic patterns for the HEDS assay have therefore been puzzling since 1991. Here we established a novel assay and used the model enzyme ScGrx7 from yeast and PfGrx from Plasmodium falciparum to test several possible causes for the sequential kinetics such as pre-enzymatic GSH depletion, simultaneous binding of a glutathionylated substrate and GSH, as well as substrate or product inhibition. Furthermore, we analyzed the non-enzymatic reaction between HEDS and GSH by HPLC and mass spectrometry suggesting that such a reaction is too slow to explain high Grx activities in the assay. The most plausible interpretation of our results is a direct Grx-catalyzed reduction of HEDS. Physiological implications of this alternative mechanism and of the Grx-catalyzed reduction of non-glutathione disulfide substrates are discussed.     

Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study

There is substantial evidence that circulating estrogens promote the proliferation of breast cancer. Consequently, adjuvant hormonal treatment strategies targeting estrogen action have been established. Such hormonal therapies include selective estrogen receptor modulators, such as tamoxifen, which interfere at the estrogen receptors directly, or non-steroidal aromatase inhibitors, such as anastrozole and letrozole, which inhibit estrogen synthesis through blocking the aromatase, a key enzyme of estrogen production. Despite considerable therapeutic success, in several cases, the use of these drugs is limited by side effects that have been described to significantly impair the adherence of patients to endocrine treatment. However, objective data concerning patient adherence and its clinical relevance are limited. One promising approach to check patient-reported adherence is drug monitoring in human plasma. Therefore, a liquid chromatography–tandem mass spectrometry method to determine the plasma concentrations of tamoxifen, anastrozole, and letrozole has been developed and fully validated according to guidelines for clinical and forensic toxicology. The validation criteria evaluated were selectivity, linearity, accuracy and precision, limit of quantification, recovery and matrix effects, sample stability, and carryover. The six-point calibration curves showed linearity over the range of concentrations from 25 to 500 ng/ml for tamoxifen, 5 to 200 ng/ml for anastrozole, and 10 to 300 ng/ml for letrozole. The intra- and inter-day precision and accuracies were always better than 15%. The validated procedure was successfully applied to a clinical study (Patient-Reported Outcomes in Breast Cancer Patients undergoing Endocrine Therapy, PRO-BETh). A major aim of PRO-BETh study is the comprehensive evaluation of adherence to treatment in pre- and post-menopausal women with breast cancer. Plasma samples of 310 breast cancer patients undergoing anti-estrogen therapy were analyzed. Eight samples did not contain a quantifiable amount of drug, strongly indicating non-adherence of the corresponding patients to adjuvant breast cancer treatment. Furthermore, plasma concentrations at the lower end of the observed plasma level distribution might represent a hint but not a confirmation for non-adherence in terms of non-daily and irregular intake of the prescribed drug.     

Adsorption studies of a microporous phthalocyanine network polymer

The adsorption/desorption of N2 at 77 K and the adsorption from aqueous solution at 298 K of four organic probe molecules of different sizes (phenol, 4-nitrophenol, orange II, naphthol green B) were studied for a phthalocyanine network polymer of intrinsic microporosity (PIM) and for an activated carbon (Darco 20-40 mesh). N2 sorption analysis gave similar surface areas for the PIM and the carbon (610 and 545 m2 g(-1), respectively) but showed differences in pore size distribution, the PIM being essentially microporous (pore size < 2 nm), with a high proportion of ultramicropores (<0.7 nm), while the carbon had a broader pore size distribution, extending into the mesopore region. The carbon acted as an adsorbent for all the organic probe molecules studied, while the PIM was more selective, adsorbing the smaller molecules but rejecting the large dye naphthol green B. The PIM offers selectivity combined with a well-defined chemical structure incorporating catalytic sites.     

Facile migratory insertion of a N-heterocyclic carbene into a ruthenium-carbon double bond: a new type of reaction of a NHC ligand

The reaction of [RuCp(IPri)(CH3CN)2]PF6 (IPri = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) with HCCR (R = COOMe, COOEt, COMe) yields the allyl carbene complexes [RuCp(=C(R)-eta3-CHC(R)CH-IPri)]PF6. This conversion involves selective head-to-tail coupling of two alkynes and an unusual migratory insertion of the N-heterocyclic carbene into the ruthenium-carbon double bond of a ruthenacyclopentatriene intermediate.     

Sodium Trinitratouranylate(VI) Na[UO2(NO3)3]

Although potassium, rubidium, and cesium uranyl nitrate have been characterized a long time ago, the crystal structure and properties of the homologous sodium compounds has not been reported yet. Na[UO₂(NO₃)₃] crystallizes in a unique structure [Pearson code cP72, cubic, P2₁3, no. 198, Z = 4, a = 10.6324(14) Å, 938 unique reflections with I_o > 2σ(I_o), R₁ = 0.0379, wR₂ = 0.0947, GooF = 1.092, T = 293 K]. The structure is characterized by an open framework built by interconnected helical chains formed by {UO₈} and {NaO₆} units. The vibrational and optical (UV/Vis absorption and luminescence) spectra match well with those of the higher alkali metal uranyl nitrates.